| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 08/08/2002 | US20020108136 Animal models for use as tools in the treatment of genetic disorders |
| 08/08/2002 | US20020108135 Methods of simulating human prostate cancer progression |
| 08/08/2002 | US20020108134 HS-40 enhancer-containing vector |
| 08/08/2002 | US20020108129 Method for producing anterior ischemic optic neuropathy in animals |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107365 Ligands for flt3 receptors |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020106778 Human PTTG polypeptide and method for producing it |
| 08/08/2002 | US20020106738 Novel Siglec gene |
| 08/08/2002 | US20020106735 Novel Bcl-2 related proline rich protein (BPR) |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106723 Receptor for latrotoxin from insects |
| 08/08/2002 | US20020106713 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/08/2002 | US20020106703 Screening cell pool for pancreatic progenitor cells; obtain mammalian cell culture, incubate with marker protein, detect those cells bound by marker protein |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106629 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin |
| 08/08/2002 | US20020106628 Methods of modifying eukaryotic cells |
| 08/08/2002 | US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function |
| 08/08/2002 | CA2437121A1 Juvenile hormone esterase |
| 08/08/2002 | CA2437016A1 Screening method for infection agent of prion disease |
| 08/08/2002 | CA2436661A1 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | CA2430921A1 Use of a vector encoding a ghrh peptide to enhance growth in multiple litters of offspring from female animals |
| 08/07/2002 | EP1229116A1 Method for preparing cell fraction containing hemangioblasts |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228094A2 Congenic animal models of non-insulin dependent diabetes mellitus |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1181352A4 Versican and epithelial-mesenchymal interaction |
| 08/07/2002 | CN2503711Y Natural simulation scorpion breeding pond |
| 08/07/2002 | CN1362994A Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant DNA molecules encoding these enzymes |
| 08/07/2002 | CN1362965A cytoplasmic transfer to de-differentiate recipient cells |
| 08/07/2002 | CN1362520A Constitution process of blank expression system for transferring spider's dragline protein gene into Bombyx mori |
| 08/07/2002 | CN1362029A Production process of dewatered mulberry leaf |
| 08/06/2002 | US6429355 Hepatitis C animal model |
| 08/06/2002 | US6429353 Endometriosis mouse model |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428782 Non-myeloablative tolerogenic treatment |
| 08/01/2002 | WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | WO2002059298A2 Gab2(p97) gene and methods of use thereof |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059263A2 Transgenic animals comprising a humanized immune system |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | WO2002059152A2 Vr-oac, an osmotically activated channel protein, nucleic acids encoding it, and uses thereof |
| 08/01/2002 | WO2002059150A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 08/01/2002 | WO2002059140A2 Ikaros rgulatory elements and uses thereof |
| 08/01/2002 | WO2002058724A2 Use of lp82 to treat body weight disorders |
| 08/01/2002 | WO2002058626A2 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | WO2002031157A3 Shrimp alkaline phosphatase |
| 08/01/2002 | WO2002016620A3 Modulation of stem cell differentiation |
| 08/01/2002 | WO2002014495A3 Enhanced homologous recombination mediated by lambda recombination proteins |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 08/01/2002 | WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/01/2002 | WO2001026454A9 Preparation and selection of donor cells for nuclear transplantation |
| 08/01/2002 | US20020104114 Mammalian animal model for use in the evaluation and treatment of brain tumors |
| 08/01/2002 | US20020104113 Nav2 channel gene-deficient non-human animals |
| 08/01/2002 | US20020104112 Ikaros regulatory elements and uses thereof |
| 08/01/2002 | US20020104110 Immunologically privileged cells and uses thereof |
| 08/01/2002 | US20020104109 Transgenic animals |
| 08/01/2002 | US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 08/01/2002 | US20020104107 Animal model for use in developing treatment for nicotine addiction and epilepsey |
| 08/01/2002 | US20020104106 Fly model for evaluating tumor propagation |
| 08/01/2002 | US20020104104 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 08/01/2002 | US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods |
| 08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 08/01/2002 | US20020102705 Regulatory sequences of the mouse villin gene - use in transgenesis |
| 08/01/2002 | US20020102645 Novel member of the lysyl oxidase gene family |
| 08/01/2002 | US20020102604 Full-length human cDNAs encoding potentially secreted proteins |
| 08/01/2002 | US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | CA2430743A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | CA2427061A1 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 07/31/2002 | EP1226752A1 Transgenic non-human mammals for monitoring change in calcium ion concentration in cells |
| 07/31/2002 | EP1226436A2 Universal fluorescent sensors |
| 07/31/2002 | EP1226276A2 Diagnostic test for cephalic pain |
| 07/31/2002 | EP1226151A2 Gene expression directed by a super-psa promoter |
| 07/31/2002 | EP1225801A1 Propagation of human hepatocytes in non-human animals |
| 07/31/2002 | EP1225800A1 Preparation and selection of donor cells for nuclear transplantation |
| 07/31/2002 | EP0700297B1 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 07/31/2002 | CN1361830A Selecting animals for parentally imprinted traits |
| 07/31/2002 | CN1361823A Global regulators of bacterial pathogenic genes, bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 07/31/2002 | CN1361659A A process of cell reprogramming through production of a heterokaryon |
| 07/31/2002 | CN1360824A Industrial method of cultivating clean fly maggot |
| 07/25/2002 | WO2002057465A2 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 07/25/2002 | WO2002057440A2 Screens and assays for agents useful in controlling parasitic nematodes |
| 07/25/2002 | WO2002057423A2 Isolating cells expressing secreted proteins |
| 07/25/2002 | WO2002057300A1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 07/25/2002 | WO2002057290A2 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
| 07/25/2002 | WO2002020830A3 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |